What is the protocol for targeted temperature management (TTM) in critically ill patients, particularly those with severe brain injury or post-cardiac arrest?

Targeted Temperature Management Protocol in Critical Patients

Primary Recommendation for Post-Cardiac Arrest Patients

Maintain targeted temperature management (TTM) between 32°C and 36°C for at least 24 hours in all comatose patients after return of spontaneous circulation (ROSC), regardless of initial cardiac rhythm. 1, 2

---

Patient Selection Algorithm

Post-Cardiac Arrest (Strongest Evidence)

Out-of-Hospital Cardiac Arrest (OHCA) with shockable rhythm (VF/pVT):

• TTM is strongly recommended - this is the only post-ROSC intervention proven to improve survival with good neurologic outcome 1, 2
• Improves neurologically intact survival (RR 1.4 for good neurologic outcome) 2

OHCA with non-shockable rhythm (asystole/PEA):

• TTM is suggested despite weaker evidence 1
• One meta-analysis showed decreased hospital mortality (RR 0.86,95% CI 0.76-0.99) but no difference in neurologic outcome 1
• Given poor prognosis and lack of alternatives, implement TTM 1

In-Hospital Cardiac Arrest (IHCA):

• TTM is suggested for all rhythms in comatose patients 1, 2
• Recent analysis showed hypothermia at 33°C associated with better day 90 neurologic outcomes compared to normothermia (16.4% vs 5.8%, p=0.03) 3

---

Temperature Target Selection

Select a constant target temperature between 32°C and 36°C - the exact temperature within this range remains uncertain 1

Key Evidence:

• The landmark TTM trial (950 patients) found no difference between 33°C vs 36°C in mortality or neurologic outcomes at 6 months 1
• TTM at 33°C was associated with more bradycardia, elevated lactate, and increased vasopressor requirements compared to 36°C 1
• Critical point: Both groups had strict fever prevention, suggesting temperature control itself (avoiding hyperthermia) may be more important than the specific target 1

Practical Approach:

• Start with 36°C as default target - easier to achieve, fewer hemodynamic complications 1
• Consider 33-34°C for patients with witnessed arrest, short downtime, and shockable rhythm (highest likelihood of benefit) 1
• Avoid temperatures below 32°C or above 36°C 1

---

Implementation Protocol

Phase 1: Induction (First 4 Hours)

Begin TTM as soon as feasible after ROSC - animal data suggests earlier cooling produces better outcomes 1, 2, 4

Do NOT use large-volume cold saline infusion during transport:

• Multiple RCTs show no benefit and potential harm 1
• Associated with increased re-arrest after ROSC and pulmonary edema 1
• One RCT showed cold fluid (4°C) infusion increased complications 1

Preferred cooling methods:

• Surface cooling devices (Arctic Sun, blankets with feedback control) 4
• Intravascular cooling catheters for precise control 4
• Target rate: reach goal temperature within 4 hours 5

Phase 2: Maintenance (24-48 Hours)

Maintain constant target temperature for minimum 24 hours 1, 2

• The two largest RCTs used 24-28 hours of temperature control 1
• No evidence that 72 hours is superior to 24 hours 1
• Minimize temperature variability - stability is critical 4

Monitor and manage complications:

Shivering (most common):

• Increases metabolic demand and prevents effective cooling 1, 4
• Stepwise approach: skin counter-warming → sedation (propofol/dexmedetomidine) → opioids (fentanyl) → neuromuscular blockade if refractory 1, 4
• Use sedation depth monitoring (BIS or EEG) when using neuromuscular blockade 1

Hemodynamic effects:

• Expect bradycardia at 33°C (may be beneficial - associated with good outcomes) 1
• Increased vasopressor requirements common at lower temperatures 1
• Target MAP adequate for perfusion (typically >65 mmHg, individualize based on pre-existing hypertension) 2

Metabolic derangements:

• Hyperglycemia common - target glucose 140-180 mg/dL 4
• Hypokalemia and hypomagnesemia - replace aggressively 4
• Monitor potassium closely during rewarming (shifts back into cells) 4

Coagulation:

• Each 1°C drop decreases coagulation factor function by ~10% 6
• Monitor for bleeding, especially if concurrent anticoagulation 4

Phase 3: Rewarming (Slow and Controlled)

Rewarm slowly at 0.25-0.5°C per hour 4

• Rapid rewarming associated with rebound hyperthermia, electrolyte shifts, and hemodynamic instability 4
• Takes 8-16 hours to reach normothermia from 33°C 4

Phase 4: Normothermia (72 Hours Total)

Prevent fever aggressively for at least 72 hours after ROSC 1, 2

• Hyperthermia consistently associated with worse neurologic outcomes 1, 2
• Maintain temperature <37.5°C using active temperature management 1

---

Seizure Management During TTM

Perform EEG promptly in all comatose post-arrest patients (Class I recommendation) 2

• Seizures/status epilepticus occur in 12-22% of comatose post-arrest patients 2
• Continue EEG monitoring throughout coma period 2

Do NOT use prophylactic anticonvulsants:

• No benefit demonstrated in RCTs 2
• May cause harm through prolonged sedation and delayed awakening 2

Treat seizures when detected using standard status epilepticus protocols 2

---

Traumatic Brain Injury (TBI) - Different Approach

For severe TBI, target normothermia (35-37°C), NOT hypothermia 1

• Multiple RCTs and meta-analyses show no benefit of hypothermia (32-35°C) for mortality or neurologic outcome in TBI 1
• Hyperthermia is associated with worse outcomes, higher mortality, and prolonged ICU stay 1

Exception - Refractory intracranial hypertension:

• Consider TTM at 34-35°C to lower ICP when tier 1 and 2 treatments have failed 1, 6
• TTM at 36-36.5°C within 72 hours of TBI associated with lower average ICP 1

---

Critical Pitfalls to Avoid

Timing errors:

• Do NOT delay TTM initiation - begin in ED if ICU unavailable 7
• Do NOT use cold saline boluses pre-hospital 1

Temperature management errors:

• Do NOT allow hyperthermia at any point, especially first 72 hours 2
• Do NOT rewarm rapidly - causes rebound complications 4
• Do NOT use therapeutic hypothermia in TBI (except refractory ICP) 1

Prognostication errors:

• Do NOT prognosticate before 72 hours post-ROSC 2
• Extend observation if residual sedation or recent seizure treatment 2
• Sedatives have delayed clearance during hypothermia 1

Monitoring errors:

• Do NOT rely on clinical exam alone - use continuous EEG 2
• Do NOT skip neuromuscular blockade monitoring if used - prevents awareness 1

Patient selection errors:

• Total CPR duration >25 minutes associated with 100% mortality in one series 7
• Absence of light reflexes strongly predicts poor outcome 7

---

Special Populations

Pediatric patients:

• Maintain normothermia (avoid hyperthermia) 1
• Do NOT use TTM 32-34°C - no benefit demonstrated and may be harmful 1

Shock patients:

• Post-hoc analysis suggests possible worse outcomes with 33°C in patients with shock at admission 1
• Consider 36°C target in hemodynamically unstable patients 1